By screening for chromatin regulators with CRISPR-Cas9, Griffin et al. identified that SETDB1 and other members of the HUSH and KAP1 complexes act as mediators of immune escape in ICB-treated mouse tumor models. The gene discussed is SETDB1; the disease is neoplasm.